For most IVF patients, frozen and fresh embryo transfers produce similar live birth rates. Frozen transfers are clearly better when you need PGT-A results, when OHSS risk is high, or when progesterone rises too early during stimulation. But fresh transfers may be better for low-prognosis patients — and the growing reliance on programmed FET cycles raises legitimate concerns about preeclampsia risk that patients deserve to know about.
Fresh vs Frozen: The Basics
In a fresh embryo transfer, an embryo created during your IVF stimulation cycle is transferred to your uterus 3–5 days after egg retrieval — in the same cycle as stimulation. Your body is still under the influence of the hormones used to stimulate your ovaries.
In a frozen embryo transfer (FET), embryos are vitrified (flash-frozen) after retrieval and stored. Transfer happens in a later cycle — typically 4–8 weeks later — after your body has recovered from stimulation and your uterine lining has been prepared separately.
A freeze-all cycle means all embryos from a retrieval are frozen with no fresh transfer attempted. This has become increasingly standard at many US clinics, driven by PGT-A adoption, OHSS prevention, and the belief that FET outcomes are superior. But as we'll explore, the evidence is more nuanced than the trend suggests.
Why Freezing Has Become the Default
Several factors have pushed clinics toward freeze-all:
- PGT-A testing requires freezing — genetic results take 1–2 weeks, so embryos must be frozen while you wait
- OHSS prevention — avoiding fresh transfer after high-response stimulation reduces hyperstimulation risk
- Vitrification technology — modern flash-freezing achieves 95%+ embryo survival, making freezing virtually lossless
- Uterine receptivity — theory holds that the uterine lining is more receptive after the stimulation hormones have cleared
- Scheduling convenience — separating retrieval from transfer gives clinics and patients more flexibility
Success Rates: What the Data Shows
| Outcome | Fresh Transfer | Frozen Transfer (FET) |
|---|---|---|
| Live birth rate per transfer (blastocyst) | 35–50% | 35–55% |
| Live birth rate — euploid embryo (PGT-A tested) | N/A (requires freeze) | 55–65% |
| Miscarriage rate | 15–25% | 10–20% |
| Embryo survival after thaw | N/A | 95–99% (vitrification) |
| OHSS risk | Present (up to 5%) | Eliminated |
For the general IVF population, these numbers are remarkably close. Multiple randomized controlled trials confirm that cumulative live birth rates are similar between freeze-all and fresh transfer strategies in normal and high responders.
A 2025 trial published in The BMJ found that for women with a low prognosis (older age, low ovarian reserve, or prior poor response), fresh embryo transfer resulted in a 40% live birth rate compared to 32% for frozen transfer. The researchers concluded that freeze-all is not supported as a routine strategy for low-prognosis patients.
This is a critical finding that challenges the one-size-fits-all freeze-all trend. For patients who produce only a few embryos, the added cost, time, and potential risks of a separate FET cycle may not be justified — and fresh transfer may actually produce better results.
The Preeclampsia Question
This is the part of the frozen vs fresh conversation that most clinics gloss over — and it matters enormously for pregnancy safety.
A substantial body of research — including systematic reviews and large population studies — has found that pregnancies resulting from frozen embryo transfers are associated with a significantly higher risk of preeclampsia and hypertensive disorders compared to fresh transfers or spontaneous conception.
One prospective study found preeclampsia rates of 12.8% in programmed FET cycles vs 4.7% in fresh transfer cycles.
Why This Happens: The Corpus Luteum Connection
The leading explanation centers on the corpus luteum — the structure left behind in the ovary after egg retrieval. In a fresh transfer, the corpus luteum produces hormones (particularly relaxin) that support cardiovascular adaptation to pregnancy. In a programmed/artificial FET cycle, there's no ovulation and no corpus luteum — hormone support is provided externally with estrogen and progesterone pills or patches.
Without the corpus luteum's natural hormones, the body may not adapt to pregnancy as effectively, leading to impaired blood vessel function and increased preeclampsia risk.
Each Transfer Type Carries Different Risks
⚡ Fresh Transfer Risks
- Higher risk of preterm birth
- Higher risk of low birth weight
- Higher risk of small-for-gestational-age (SGA) babies
- OHSS risk (can be severe in high responders)
- Suboptimal lining if progesterone rises too early
❄️ Frozen Transfer Risks
- Higher risk of preeclampsia (especially programmed cycles)
- Higher risk of high birth weight / large-for-gestational-age (LGA)
- Higher risk of gestational hypertension
- No OHSS risk (this is the major advantage)
- Small risk of embryo not surviving thaw (~1–5%)
The Protocol Matters: Natural vs Programmed FET
Not all FET cycles are equal when it comes to preeclampsia risk. There are three main ways to prepare the uterine lining for a frozen transfer:
| FET Protocol | How It Works | Corpus Luteum? | Preeclampsia Risk |
|---|---|---|---|
| Programmed / Artificial | Estrogen + progesterone pills/patches; no ovulation | No | Highest |
| Modified Natural Cycle | Monitor your natural ovulation; trigger if needed; add progesterone support | Yes | Similar to natural conception |
| Stimulated / Mild Stim | Low-dose medication to support follicle growth + trigger; produces corpus luteum | Yes | Similar to natural conception |
The critical takeaway: modified natural cycle FET — where you ovulate and form a corpus luteum — appears to carry no elevated preeclampsia risk compared to spontaneous conception. If you're having a frozen transfer, ask your clinic about natural cycle FET as an alternative to a programmed cycle, especially if you have regular cycles.
When Fresh Transfer Makes More Sense
Women with low ovarian reserve, older age, or prior poor response. The 2025 BMJ trial showed 40% vs 32% live birth rates favoring fresh. Every embryo counts — avoiding the freeze/thaw cycle removes one variable.
If you're not doing genetic testing, there's no technical reason to freeze first. A fresh transfer saves 4–8 weeks and $3,000–$6,000 in FET costs.
If progesterone levels remain appropriate during stimulation and the lining looks good, a fresh transfer avoids the need for a separate cycle entirely.
If you have a personal or family history of preeclampsia, chronic hypertension, or other cardiovascular risk factors, a fresh transfer avoids the elevated HDP risk associated with programmed FET.
When Frozen Transfer Makes More Sense
Non-negotiable — results take 1–2 weeks, so embryos must be frozen. This is the most common reason for freeze-all.
PCOS, high responders, or elevated estrogen levels. Freeze-all prevents the dangerous combination of OHSS + early pregnancy. This is a clear medical indication.
If progesterone rises too early during stimulation (above ~1.5 ng/mL before trigger), the lining may be out of sync with the embryo. Freezing and transferring in a controlled cycle improves timing.
If you're doing multiple retrieval cycles before transferring — common for older patients or those building embryo banks — all embryos are frozen until you're ready.
Cost Comparison
| Cost Component | Fresh Transfer | FET (Separate Cycle) |
|---|---|---|
| Transfer procedure | Included in IVF cycle fee | $3,000–$6,000 |
| Lining prep medications | N/A | $400–$1,500 |
| Monitoring (ultrasound + bloodwork) | Included in IVF cycle | $500–$1,500 |
| Embryo freezing | $0 (fresh) | $1,000–$2,000 |
| Annual storage | $0 | $500–$1,000/year |
| Additional cost vs fresh | — | $4,000–$10,000+ |
Budget clinics offer significantly lower FET pricing — CNY Fertility charges $650–$1,940 for a frozen transfer, dramatically reducing the fresh-vs-frozen cost gap.
→ Check if your state mandate covers FET cycles
→ Using HSA/FSA funds for frozen transfers
Questions to Ask Your Clinic
- "Do you recommend freeze-all for all patients, or is fresh transfer an option for my situation?" — Clinics that blanket freeze-all regardless of diagnosis may be prioritizing scheduling over individualized care.
- "What type of FET protocol do you use — programmed or natural cycle?" — If they default to programmed cycles, ask about modified natural cycle FET to preserve the corpus luteum and reduce preeclampsia risk.
- "What is my personal OHSS risk, and does that justify freeze-all?" — If your OHSS risk is low, a fresh transfer may save time and money without added safety concerns.
- "What is your clinic's live birth rate for FET vs fresh transfers in patients my age?" — Clinic-specific data is more relevant than national averages.
- "If I'm low-prognosis, does the evidence support freeze-all for me?" — The 2025 BMJ data suggests it may not.
- "What are the full costs of a FET cycle at your clinic, including monitoring, medications, and the procedure?" — Get the total, not just the transfer fee.
Supporting Your Transfer — Fresh or Frozen
→ More supplement and lifestyle guidance at LifeFertile.com
Frequently Asked Questions
Neither is universally better. For most patients, live birth rates are similar. FET is preferred when PGT-A testing is needed, OHSS risk is high, or the lining isn't optimal. Fresh transfer may be better for low-prognosis patients and avoids the added cost and time of a separate FET cycle. The best choice depends on your individual diagnosis and response to stimulation.
FET success rates depend on embryo quality and patient age. For PGT-A tested euploid blastocysts, live birth rates are approximately 55–65% per transfer. For untested blastocysts, rates range from 30–50% depending on age. Modern vitrification achieves embryo survival rates above 95%, so very few embryos are lost in the freeze/thaw process.
Modern vitrification (flash-freezing) achieves survival rates above 95%. This is a dramatic improvement from older slow-freezing methods that achieved only 70–80%. The vast majority of embryos survive thawing with no measurable impact on pregnancy rates. Vitrification has been the standard method since the late 2010s and is now considered extremely reliable.
Research shows that FET — particularly programmed/artificial cycles where no ovulation occurs — is associated with higher preeclampsia risk compared to fresh transfers. This may relate to the absence of a corpus luteum. Modified natural cycle FET, where ovulation produces a corpus luteum, appears to carry no elevated risk. Ask your clinic about natural cycle FET protocols.
A FET cycle typically costs $3,000–$6,000 for the procedure, plus $400–$1,500 for lining preparation medications, plus embryo freezing ($1,000–$2,000) and annual storage ($500–$1,000). Budget clinics like CNY offer FET for $650–$1,940. HSA and FSA funds can be used for all FET-related costs.
A freeze-all cycle means all embryos are frozen after retrieval with no fresh transfer. This is standard when doing PGT-A (results take 1–2 weeks), when OHSS risk is high, or when progesterone rises too early during stimulation. Transfer happens in a subsequent cycle, typically 4–8 weeks later, after your body recovers from stimulation.
Explore Your IVF Options
From PGT-A to mini IVF to AI embryo selection — understand every option before your next cycle.
Is PGT-A Worth It? →